133 related articles for article (PubMed ID: 350503)
1. Hormonal control of breast cancer growth in women and rats.
Pearson OH; Manni A
Curr Top Exp Endocrinol; 1978; 3():75-92. PubMed ID: 350503
[No Abstract] [Full Text] [Related]
2. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract][Full Text] [Related]
3. Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
Sweeney MJ; Poore GA; Kornfeld EC; Bach NJ; Owen NV; Clemens JA
Cancer Res; 1975 Jan; 35(1):106-9. PubMed ID: 1109784
[TBL] [Abstract][Full Text] [Related]
4. Prolactin and breast cancer.
Wilson RG; Buchan R; Roberts MM; Forrest AP
Proc R Soc Med; 1973 Sep; 66(9):865-6. PubMed ID: 4805083
[No Abstract] [Full Text] [Related]
5. Prolactin and breast cancer.
Sherman L
CA Cancer J Clin; 1975; 25(5):258-63. PubMed ID: 808256
[No Abstract] [Full Text] [Related]
6. Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.
Jordan VC
Cancer Invest; 1988; 6(5):589-95. PubMed ID: 3063338
[No Abstract] [Full Text] [Related]
7. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine in the treatment of advanced breast cancer.
Barrett A; Morgan L; Raggatt PR; Hobbs JR
Clin Oncol; 1976 Dec; 2(4):373-7. PubMed ID: 1037393
[No Abstract] [Full Text] [Related]
9. [Ultrastructural study of rat mammary tumors and human breast cancer cells following treatment with tamoxifen].
Kamioki S
Gan No Rinsho; 1986 Nov; 32(14):1809-18. PubMed ID: 3099030
[TBL] [Abstract][Full Text] [Related]
10. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
[TBL] [Abstract][Full Text] [Related]
11. Prolactin and breast cancer.
Schyve PM; Smithline F; Meltzer HY
Psychopharmacol Bull; 1978 Jan; 14(1):17-9. PubMed ID: 625530
[No Abstract] [Full Text] [Related]
12. The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
Paterson AG; Turkes A; Groom GV; Webster DJ
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):919-22. PubMed ID: 6684048
[TBL] [Abstract][Full Text] [Related]
13. Studies with lergotrile mesylate in acromegaly.
Kleinberg DL; Schaaf M; Frantz AG
Fed Proc; 1978 Jun; 37(8):2198-201. PubMed ID: 658458
[No Abstract] [Full Text] [Related]
14. Ergolines as potential prolactin and mammary tumor inhibitors.
Cassady JM; Floss HG
Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
[No Abstract] [Full Text] [Related]
15. Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in rats.
Formelli F; Zaccheo T; Di Salle E; Ornati G; Di Marco A
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1545-51. PubMed ID: 6416848
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
[No Abstract] [Full Text] [Related]
17. Chemoprevention for breast cancer: are we ready?
Kiang DT
J Natl Cancer Inst; 1991 Apr; 83(7):462-3. PubMed ID: 2005624
[No Abstract] [Full Text] [Related]
18. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin.
Rose DP; Gottardis M; Noonan JJ
Anticancer Res; 1983; 3(5):323-5. PubMed ID: 6139974
[TBL] [Abstract][Full Text] [Related]
19. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate.
Sherman BM; Swanson JA; Chapler FK
Fertil Steril; 1978 Mar; 29(3):291-5. PubMed ID: 565303
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen for the prevention of breast cancer: yes.
Vogel VG; Saenz M
Important Adv Oncol; 1995; ():187-200. PubMed ID: 7672805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
